Healthcare

Survey Reveals American Adults Demand Elimination of Health Inequities

Survey Reveals American Adults Demand Elimination of Health Inequities

A survey by Johns Hopkins School of Nursing's Institute for Policy Solutions finds that American adults strongly support eliminating health inequities, urging policymakers to act.

April 24, 2026
HeartBeam Partners with Mount Sinai to Develop AI-Driven ECG Algorithms

HeartBeam Partners with Mount Sinai to Develop AI-Driven ECG Algorithms

HeartBeam's collaboration with Mount Sinai aims to advance AI-enabled ECG analysis, reinforcing its role in the shift toward data-driven remote cardiac monitoring.

April 24, 2026
Earth Science Tech Positions Itself for Telehealth's Next Phase with Integrated Platform

Earth Science Tech Positions Itself for Telehealth's Next Phase with Integrated Platform

Earth Science Tech Inc. is aligning with the evolution of telehealth from simple video visits to a comprehensive care model through its integrated platform that combines telemedicine, compounding pharmaceuticals, and patient services.

April 24, 2026
Hansen Orthodontics Expands Invisalign Availability in Wichita Under Founder's Direct Oversight

Hansen Orthodontics Expands Invisalign Availability in Wichita Under Founder's Direct Oversight

Hansen Orthodontics increases Invisalign appointment capacity for spring 2026, emphasizing founder-led care and Silver Plus provider status as alternatives to corporate dental chains.

April 24, 2026
Telomir Pharmaceuticals Closes TELI Acquisition, Secures Global Rights to Lead Drug Candidate

Telomir Pharmaceuticals Closes TELI Acquisition, Secures Global Rights to Lead Drug Candidate

Telomir Pharmaceuticals completed its acquisition of TELI Pharmaceuticals, obtaining sole global rights to Telomir-1, a drug aimed at treating advanced breast cancer and targeting aging-related diseases, with a $1 million upfront payment and up to $4 million in milestones.

April 24, 2026
Lantern Pharma to Showcase AI Co-Scientist Platform withZeta.ai in Live Public Demo

Lantern Pharma to Showcase AI Co-Scientist Platform withZeta.ai in Live Public Demo

Lantern Pharma will host its first live demonstration of the withZeta.ai AI co-scientist platform on April 30, 2026, showcasing its ability to accelerate oncology drug discovery and marking a potential new revenue stream through a subscription model.

April 24, 2026
SureNano Science Advances GLP-1 Drug Candidate Toward Clinical Trials, Expands Investor Outreach

SureNano Science Advances GLP-1 Drug Candidate Toward Clinical Trials, Expands Investor Outreach

SureNano Science Ltd. is moving its lead obesity and diabetes drug GEP-44 into FDA IND-enabling studies with LabCorp while broadening investor communications through a partnership with Investor Brand Network.

April 24, 2026
Scinai Immunotherapeutics Raises $2.61M to Expand CDMO Platform and Advance Pipeline

Scinai Immunotherapeutics Raises $2.61M to Expand CDMO Platform and Advance Pipeline

Scinai Immunotherapeutics announced a $2.61 million private placement and warrant inducement, with proceeds supporting its CDMO expansion and immunotherapy pipeline.

April 24, 2026
Strawberry Fields REIT to Report Q1 2026 Earnings, Highlighting Skilled Nursing Portfolio Performance

Strawberry Fields REIT to Report Q1 2026 Earnings, Highlighting Skilled Nursing Portfolio Performance

Strawberry Fields REIT announced its first quarter 2026 earnings release and conference call, providing investors with insights into the performance of its 143 healthcare facilities across 10 states.

April 24, 2026
Oncotelic Therapeutics Featured in NetworkNewsAudio Editorial Highlighting How Late-Stage Drug Pipelines Drive Valuation in Biotech

Oncotelic Therapeutics Featured in NetworkNewsAudio Editorial Highlighting How Late-Stage Drug Pipelines Drive Valuation in Biotech

Oncotelic Therapeutics, Inc. (OTCQB: OTLC) is featured in a NetworkNewsAudio editorial that explores how advancing drug pipelines, particularly those near commercialization, create significant value in biopharma, directly relevant to Oncotelic's oncology-focused pipeline.

April 24, 2026
Catalyst Crew Technologies Advances Telehealth Platform Deployment and Regulatory Approvals in Venezuela

Catalyst Crew Technologies Advances Telehealth Platform Deployment and Regulatory Approvals in Venezuela

Catalyst Crew Technologies Corp. is progressing with early-stage testing and regulatory alignment for its AI-driven telehealth platform in Venezuela, aiming to expand digital healthcare access in Latin America.

April 24, 2026
Oncotelic Therapeutics Highlights Partnership Strategy to Advance Pipeline and Boost Shareholder Value

Oncotelic Therapeutics Highlights Partnership Strategy to Advance Pipeline and Boost Shareholder Value

Oncotelic Therapeutics updates its partnership-driven strategy, citing a $249 million valuation boost from its GMP Biotechnology joint venture and plans for further collaborations to advance its oncology pipeline efficiently.

April 24, 2026
Lakeville Clinic Reports Early Neuropathy Improvement in Patient After Two Weeks

Lakeville Clinic Reports Early Neuropathy Improvement in Patient After Two Weeks

ALIGN Integrated Health in Lakeville, Minnesota reports that a Burnsville patient showed measurable improvement in neuropathy symptoms within two weeks of starting integrative treatment, highlighting the importance of early intervention.

April 24, 2026
American Heart Association and NFL Award $350,000 in Grants to Schools for Student Health and CPR Readiness

American Heart Association and NFL Award $350,000 in Grants to Schools for Student Health and CPR Readiness

The American Heart Association and NFL have awarded grants to 188 schools across 45 states to support physical activity, emergency readiness, and CPR training, addressing childhood obesity and cardiac emergency preparedness.

April 24, 2026
Dental Implants Can Be Affordable: Strategic Approaches to Save Without Sacrificing Quality

Dental Implants Can Be Affordable: Strategic Approaches to Save Without Sacrificing Quality

The article outlines the costs of dental implants in 2026 and provides ten proven strategies to make them more affordable, emphasizing informed decision-making and value over low price.

April 24, 2026
SS Innovations Unveils Drone, Humanoid, and Mobile OR Robotic Systems for Battlefield and Remote Surgery

SS Innovations Unveils Drone, Humanoid, and Mobile OR Robotic Systems for Battlefield and Remote Surgery

SS Innovations showcased futuristic surgical robots at SMRSC 2026, including a drone-deployed system for combat zones and a humanoid platform, aiming to expand access to robotic surgery globally.

April 24, 2026
Catalyst Crew Technologies Appoints Vilma Casanova as COO to Drive Telehealth Expansion in Venezuela

Catalyst Crew Technologies Appoints Vilma Casanova as COO to Drive Telehealth Expansion in Venezuela

Catalyst Crew Technologies Corp. has appointed Vilma Casanova as Chief Operating Officer to oversee the operational execution and scaling of its telehealth platform in Venezuela.

April 24, 2026
Tonix Pharmaceuticals Presents Preclinical Immuno-Oncology Data at AACR 2026, Highlighting Potential in Gastric Cancer and Immunotherapy

Tonix Pharmaceuticals Presents Preclinical Immuno-Oncology Data at AACR 2026, Highlighting Potential in Gastric Cancer and Immunotherapy

Tonix Pharmaceuticals announced new preclinical data for TNX-1700 and TNX-4700 at AACR 2026, showing potential in gastric cancer and as a BTLA-targeting immunotherapy, which could expand its oncology pipeline.

April 24, 2026
Helus Pharma Appoints Robert Langer and Stephen Brannan to Scientific Advisory Board, Bolstering Neuroscience Pipeline

Helus Pharma Appoints Robert Langer and Stephen Brannan to Scientific Advisory Board, Bolstering Neuroscience Pipeline

Helus Pharma adds renowned experts Dr. Robert Langer and Dr. Stephen Brannan to its Scientific Advisory Board, strengthening its drug development capabilities for mental health treatments including major depressive disorder and generalized anxiety disorder.

April 24, 2026
Novel Urine Test May Predict Bladder Cancer Treatment Response

Novel Urine Test May Predict Bladder Cancer Treatment Response

Researchers have developed a urine test that detects tumor DNA to predict residual bladder cancer after surgery and assess immunotherapy effectiveness.

April 24, 2026
Peters Creek Opens Multi-Stage Memory Care in Redmond, OR, Addressing Regional Gap in Dementia Services

Peters Creek Opens Multi-Stage Memory Care in Redmond, OR, Addressing Regional Gap in Dementia Services

Peters Creek Retirement Center has opened a memory care community in Redmond, Oregon, offering multi-stage Alzheimer's and dementia care to fill a long-standing need for local specialized senior services.

April 24, 2026
Oncotelic Therapeutics Featured in BioMedWire Editorial on Biotech Valuation Shift

Oncotelic Therapeutics Featured in BioMedWire Editorial on Biotech Valuation Shift

Oncotelic Therapeutics' inclusion in a BioMedWire editorial highlights how advancing drug pipelines are reshaping biotech valuations, with its AI-driven oncology pipeline and 45% stake in GMP Bio serving as examples of innovation translating into tangible enterprise value.

April 24, 2026
HeartBeam Partners with Mount Sinai to Develop AI-Powered ECG Algorithms

HeartBeam Partners with Mount Sinai to Develop AI-Powered ECG Algorithms

HeartBeam Inc. collaborates with Mount Sinai to advance AI-driven ECG technology, aiming to enhance remote cardiac monitoring and chronic condition management.

April 24, 2026
The Harvest Table Launches Multi Collagen Granules on Amazon, Expanding U.S. Access to Clean-Label Nutrition

The Harvest Table Launches Multi Collagen Granules on Amazon, Expanding U.S. Access to Clean-Label Nutrition

The Harvest Table's Multi Collagen Granules are now available on Amazon, marking a key step in the brand's U.S. expansion and offering consumers a transparent, nutrient-dense collagen supplement made without fillers or artificial ingredients.

April 24, 2026
American Heart Association Mourns Passing of Pioneering Cardiologist Eugene Braunwald

American Heart Association Mourns Passing of Pioneering Cardiologist Eugene Braunwald

The American Heart Association honors the legacy of Dr. Eugene Braunwald, whose seven decades of research transformed cardiovascular medicine, and highlights his enduring influence through mentorship and the Eugene Braunwald Academic Mentorship Award.

April 24, 2026
Newron Pharmaceuticals Shareholders Approve New Board Members at AGM 2026

Newron Pharmaceuticals Shareholders Approve New Board Members at AGM 2026

Newron Pharmaceuticals' AGM 2026 approved the election of two independent directors, while extraordinary motions were postponed due to lack of quorum, highlighting shareholder dynamics.

April 24, 2026
Medartis Shareholders Overwhelmingly Approve Board Proposals, Elect Yang Xu at AGM 2026

Medartis Shareholders Overwhelmingly Approve Board Proposals, Elect Yang Xu at AGM 2026

Medartis shareholders approved all board proposals with over 90.9% support and elected Yang Xu to the board, signaling strong confidence in the company's governance and strategic direction.

April 24, 2026
FastBlast Launches Interactive Quiz to Simplify Intermittent Fasting and Personalize Plans

FastBlast Launches Interactive Quiz to Simplify Intermittent Fasting and Personalize Plans

FastBlast introduces an interactive quiz that helps individuals find a personalized intermittent fasting approach based on their habits and preferences, aiming to remove guesswork and support consistency.

April 23, 2026
Physical Activity May Be Safer Than Thought for Children with Certain Heart Conditions, New Statement Says

Physical Activity May Be Safer Than Thought for Children with Certain Heart Conditions, New Statement Says

The American Heart Association's new scientific statement suggests that with proper evaluation and monitoring, physical activity can be beneficial for children with cardiomyopathies or implantable cardioverter-defibrillators, shifting away from blanket restrictions.

April 23, 2026
Cingulate Advances ADHD Treatment Toward 2026 FDA Decision with Key Milestones

Cingulate Advances ADHD Treatment Toward 2026 FDA Decision with Key Milestones

Cingulate Inc. progresses toward potential 2026 commercial launch of its ADHD treatment CTx-1301 following FDA acceptance of its New Drug Application and positive pediatric trial results, addressing a large market with unmet needs.

April 22, 2026
PreviousPage 19 of 92Next